ATE535527T1 - Verbindung mit affinität zu amyloid - Google Patents
Verbindung mit affinität zu amyloidInfo
- Publication number
- ATE535527T1 ATE535527T1 AT07743357T AT07743357T ATE535527T1 AT E535527 T1 ATE535527 T1 AT E535527T1 AT 07743357 T AT07743357 T AT 07743357T AT 07743357 T AT07743357 T AT 07743357T AT E535527 T1 ATE535527 T1 AT E535527T1
- Authority
- AT
- Austria
- Prior art keywords
- carbon
- halogen substituent
- amyloid
- affinity
- salt
- Prior art date
Links
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006140044 | 2006-05-19 | ||
JP2006324701 | 2006-11-30 | ||
PCT/JP2007/059922 WO2007135890A1 (ja) | 2006-05-19 | 2007-05-15 | 新規アミロイド親和性化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE535527T1 true ATE535527T1 (de) | 2011-12-15 |
Family
ID=38723203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07743357T ATE535527T1 (de) | 2006-05-19 | 2007-05-15 | Verbindung mit affinität zu amyloid |
Country Status (15)
Country | Link |
---|---|
US (2) | US8303935B2 (de) |
EP (1) | EP2019103B1 (de) |
JP (1) | JP5238496B2 (de) |
KR (1) | KR20090010987A (de) |
AT (1) | ATE535527T1 (de) |
AU (1) | AU2007252658B2 (de) |
BR (1) | BRPI0711818A2 (de) |
CA (1) | CA2653783A1 (de) |
ES (1) | ES2376491T3 (de) |
IL (4) | IL195378A0 (de) |
NO (1) | NO20085265L (de) |
NZ (1) | NZ573363A (de) |
RU (1) | RU2008150377A (de) |
TW (1) | TW200808795A (de) |
WO (1) | WO2007135890A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200803903A (en) * | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
ATE535527T1 (de) | 2006-05-19 | 2011-12-15 | Nihon Mediphysics Co Ltd | Verbindung mit affinität zu amyloid |
EP2042501B1 (de) * | 2006-06-21 | 2017-04-12 | Nihon Medi-Physics Co., Ltd. | Verbindung mit affinität zu amyloid |
TW200811175A (en) * | 2006-06-21 | 2008-03-01 | Nihon Mediphysics Co Ltd | Novel compound with affinity with amyloid |
WO2008056481A1 (fr) * | 2006-11-09 | 2008-05-15 | Nihon Medi-Physics Co., Ltd. | Agent d'imagerie de diagnostic radioactif |
CN101535309A (zh) * | 2006-11-17 | 2009-09-16 | 日本医事物理股份有限公司 | 对淀粉状蛋白具有亲和性的新化合物 |
NZ577511A (en) | 2006-11-30 | 2012-04-27 | Nihon Mediphysics Co Ltd | 2-Phenyl-imidazo[1,2-a]pyridine derivatives substituted with a radioactive halogen substituent |
TWI406674B (zh) | 2007-02-13 | 2013-09-01 | Nihon Mediphysics Co Ltd | Method for manufacturing diagnostic radiographic diagnostic agents |
CN101903381A (zh) * | 2007-10-24 | 2010-12-01 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物 |
CN101903383A (zh) * | 2007-10-26 | 2010-12-01 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物 |
CN101909659A (zh) * | 2007-10-30 | 2010-12-08 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物的应用及制备方法 |
EP2216052A4 (de) * | 2007-10-30 | 2012-11-21 | Nihon Mediphysics Co Ltd | Verwendung einer neuen verbindung mit affinität für amyloid und verfahren zu ihrer herstellung |
AU2008319985A1 (en) * | 2007-10-30 | 2009-05-07 | Nihon Medi-Physics Co., Ltd. | Use of novel compound having affinity for amyloid, and process for production of the same |
EP2218464A1 (de) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Verbindungen zur nichtinvasiven Messung von Aggregaten von Amyloidpeptiden |
US8476449B2 (en) | 2010-03-01 | 2013-07-02 | Nihon Medi-Physics Co., Ltd. | Radioactive iodine labeled organic compound or salt thereof |
TWI528977B (zh) | 2011-05-20 | 2016-04-11 | Nihon Mediphysics Co Ltd | New amyloid affinity products |
EP2725027B1 (de) | 2011-06-24 | 2017-03-01 | Nihon Medi-Physics Co., Ltd. | Neue verbindungen mit amyloidaffinität |
MX2015015893A (es) | 2013-05-23 | 2016-03-04 | Hoffmann La Roche | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. |
CA3055417A1 (en) | 2017-03-07 | 2018-09-13 | Nihon Medi-Physics Co., Ltd. | Radioactive fluorine-labeling precursor compound and method for producing radioactive fluorine-labeled compound using same |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4833149A (en) | 1986-09-22 | 1989-05-23 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines |
US4727145A (en) * | 1986-09-22 | 1988-02-23 | Ortho Pharmaceutical Corporation | 2- Or 3- aryl substituted imidazo [1,2-a]pyridines |
US4871745A (en) | 1986-09-22 | 1989-10-03 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents |
US4791117A (en) | 1986-09-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers |
DE4327027A1 (de) | 1993-02-15 | 1994-08-18 | Bayer Ag | Imidazoazine |
BR9611047A (pt) | 1995-10-17 | 2000-03-08 | Searle & Co | Processo de deteção de ciclo oxigenase-2 |
US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
CA2340394A1 (en) | 1998-08-20 | 2000-03-02 | Jorge R. Barrio | Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles |
JP4025468B2 (ja) | 1999-07-29 | 2007-12-19 | 三井化学株式会社 | 有機電界発光素子 |
WO2001074815A2 (en) | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | Phenyl-substituted imidazopyridines |
US20010051632A1 (en) | 2000-03-31 | 2001-12-13 | Wenying Chai | Phenyl-substituted indolizines and tetrahydroindolizines |
WO2001074813A2 (en) * | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
US6514969B2 (en) | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
DE10040016A1 (de) * | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
RU2324686C2 (ru) | 2000-08-24 | 2008-05-20 | Юнивесити Оф Питсбэг | ПРОИЗВОДНЫЕ ТИОФЛАВИНА, СВЯЗЫВАЮЩИЕ АМИЛОИД, СПОСОБ ОБНАРУЖЕНИЯ in vivo ОТЛОЖЕНИЙ АМИЛОИДА И СПОСОБ РАСПОЗНАВАНИЯ БОЛЕЗНИ АЛЬЦГЕЙМЕРА |
IL157359A0 (en) | 2001-02-26 | 2004-02-19 | Bristol Myers Squibb Pharma Co | A radiopharmaceutical composition containing an ascorbic acid analog |
US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
JP4317955B2 (ja) | 2001-04-23 | 2009-08-19 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | アミロイド斑凝集阻害剤および診断用造影剤 |
US7186714B2 (en) | 2001-06-21 | 2007-03-06 | Smithkline Beecham Corporation | Imidazo[1,2-α]pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
JP4436928B2 (ja) | 2001-08-27 | 2010-03-24 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | スチルベン誘導体、およびアミロイド斑の結合および画像化のためのその使用 |
GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
AU2003242233A1 (en) | 2002-06-12 | 2003-12-31 | Bf Research Institute, Inc. | Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation |
JPWO2004035522A1 (ja) * | 2002-08-30 | 2006-02-16 | 株式会社 ビーエフ研究所 | プリオン蛋白蓄積性疾患の診断プローブおよび治療薬ならびにプリオン蛋白の染色剤 |
WO2004043497A1 (en) | 2002-11-05 | 2004-05-27 | Ion Beam Applications S.A. | Stabilzation of radiopharmceuticals labeled with 18-f |
EP1699799B1 (de) * | 2003-12-31 | 2007-05-16 | Schering-Plough Ltd. | Bekämpfng von parasiten in tieren durch anwendung von imidazo[1,2-b]pyridazinderivaten |
TW200803903A (en) | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
ATE535527T1 (de) | 2006-05-19 | 2011-12-15 | Nihon Mediphysics Co Ltd | Verbindung mit affinität zu amyloid |
EP2042501B1 (de) * | 2006-06-21 | 2017-04-12 | Nihon Medi-Physics Co., Ltd. | Verbindung mit affinität zu amyloid |
CN101903381A (zh) | 2007-10-24 | 2010-12-01 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物 |
CN101903383A (zh) | 2007-10-26 | 2010-12-01 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物 |
CN101909659A (zh) | 2007-10-30 | 2010-12-08 | 日本医事物理股份有限公司 | 对淀粉样蛋白具有亲和性的新化合物的应用及制备方法 |
-
2007
- 2007-05-15 AT AT07743357T patent/ATE535527T1/de active
- 2007-05-15 TW TW096117253A patent/TW200808795A/zh unknown
- 2007-05-15 ES ES07743357T patent/ES2376491T3/es active Active
- 2007-05-15 RU RU2008150377/04A patent/RU2008150377A/ru not_active Application Discontinuation
- 2007-05-15 EP EP07743357A patent/EP2019103B1/de not_active Not-in-force
- 2007-05-15 AU AU2007252658A patent/AU2007252658B2/en not_active Expired - Fee Related
- 2007-05-15 JP JP2008516608A patent/JP5238496B2/ja not_active Expired - Fee Related
- 2007-05-15 BR BRPI0711818-0A patent/BRPI0711818A2/pt not_active IP Right Cessation
- 2007-05-15 NZ NZ573363A patent/NZ573363A/en not_active IP Right Cessation
- 2007-05-15 CA CA002653783A patent/CA2653783A1/en not_active Abandoned
- 2007-05-15 WO PCT/JP2007/059922 patent/WO2007135890A1/ja active Application Filing
- 2007-05-15 KR KR1020087028172A patent/KR20090010987A/ko not_active Application Discontinuation
- 2007-05-15 US US12/227,487 patent/US8303935B2/en not_active Expired - Fee Related
-
2008
- 2008-11-19 IL IL195378A patent/IL195378A0/en unknown
- 2008-12-16 NO NO20085265A patent/NO20085265L/no not_active Application Discontinuation
-
2010
- 2010-11-30 IL IL209651A patent/IL209651A0/en unknown
- 2010-11-30 IL IL209650A patent/IL209650A0/en unknown
- 2010-11-30 IL IL209649A patent/IL209649A0/en unknown
-
2012
- 2012-06-29 US US13/537,422 patent/US8506930B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2653783A1 (en) | 2007-11-29 |
IL195378A0 (en) | 2011-08-01 |
US8303935B2 (en) | 2012-11-06 |
BRPI0711818A2 (pt) | 2011-12-13 |
TW200808795A (en) | 2008-02-16 |
EP2019103B1 (de) | 2011-11-30 |
NO20085265L (no) | 2009-02-18 |
RU2008150377A (ru) | 2010-06-27 |
IL209650A0 (en) | 2011-02-28 |
KR20090010987A (ko) | 2009-01-30 |
JPWO2007135890A1 (ja) | 2009-10-01 |
US20090252679A1 (en) | 2009-10-08 |
IL209651A0 (en) | 2011-02-28 |
JP5238496B2 (ja) | 2013-07-17 |
WO2007135890A1 (ja) | 2007-11-29 |
EP2019103A1 (de) | 2009-01-28 |
IL209649A0 (en) | 2011-02-28 |
AU2007252658B2 (en) | 2012-03-29 |
ES2376491T3 (es) | 2012-03-14 |
US8506930B2 (en) | 2013-08-13 |
EP2019103A4 (de) | 2010-05-05 |
AU2007252658A1 (en) | 2007-11-29 |
US20120271053A1 (en) | 2012-10-25 |
NZ573363A (en) | 2012-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE535527T1 (de) | Verbindung mit affinität zu amyloid | |
IL194889A0 (en) | Compound having affinity to amyloid | |
ME01992B (me) | Jedinjenje diarilhidantoina | |
DK1740584T5 (da) | Kondenseret chinolinderivat og anvendelse deraf | |
IL198995A0 (en) | Novel compound having affinity for amyloid | |
MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
BRPI0607018A2 (pt) | combinações sinérgicas de compostos ativas fungicidas | |
WO2009016462A3 (en) | Substituted bicyclolactam compounds | |
WO2007106192A3 (en) | Inhibitors of iap | |
EA200801063A1 (ru) | Диароматические амины | |
MY184464A (en) | Combined use of cholestanol derivative | |
DE602006020295D1 (de) | Azabenzimidalzolderivate, ihre herstellung und ihre verwendung als antikrebsmittel | |
WO2007038425A3 (en) | Anti-viral compouinds | |
MX2010001566A (es) | Derivado de aminopirazolamida. | |
WO2007025089A3 (en) | Triazole compounds and methods of making and using the same | |
EA200970555A1 (ru) | Трициклическое соединение и его медицинское применение | |
ECSP088374A (es) | Formulacion de aerosol para inhalacion | |
TW200640970A (en) | Flame retardant and flame-retardant resin composition containing the same and its use | |
MX2010001304A (es) | Compuestos terapeuticos. | |
WO2008063548A3 (en) | 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents | |
UA97388C2 (ru) | Противопаразитарные агенты | |
ATE276259T1 (de) | Dihydroporphyrinderivate und ihre verwendung | |
TW200640464A (en) | Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient | |
TH98285A (th) | Smac เปปติโดมิเมติค (peptidomimetics) ที่ใช้ประโยชน์ในฐานะเป็นสารยับยั้งของ IAP | |
TH106084B (th) | ตัวกระทำต้านปรสิต |